2015
Non‐alcoholic fatty liver disease following liver transplantation: a clinical review
Merola J, Liapakis A, Mulligan DC, Yoo PS. Non‐alcoholic fatty liver disease following liver transplantation: a clinical review. Clinical Transplantation 2015, 29: 728-737. PMID: 26147308, DOI: 10.1111/ctr.12585.Peer-Reviewed Original ResearchConceptsNon-alcoholic steatohepatitisLiver transplantationRisk factorsNon-alcoholic fatty liver diseasePost-transplant metabolic syndromePost-transplant settingCardiovascular risk factorsPost-transplantation outcomesSignificant survival benefitFatty liver diseaseCause of deathCardiovascular mortalitySurvival benefitMetabolic syndromeLiver diseaseClinical reviewPatient populationSurgical approachTreatment approachesTransplantationRecent evidenceIndicationsSteatohepatitisTransplantSyndrome
2007
Kluyvera co‐infection in two solid organ transplant recipients: an emerging pathogen or a colonizer bystander?
Cheruvattath R, Balan V, Stewart R, Heilman RL, Mulligan DC, Kusne S. Kluyvera co‐infection in two solid organ transplant recipients: an emerging pathogen or a colonizer bystander? Transplant Infectious Disease 2007, 9: 83-86. PMID: 17313481, DOI: 10.1111/j.1399-3062.2006.00198.x.Peer-Reviewed Original ResearchConceptsSolid organ transplant recipientsOrgan transplant recipientsTransplant recipientsDeceased donor kidney transplantAlpha-1 antitrypsin deficiencyDonor liver transplantationDonor kidney transplantsFocal segmental glomerulosclerosisAntibiotic coverageLiver transplantationTransplant patientsKidney transplantRenal failureUrinary infectionUrine cultureImmunocompetent hostsPatient populationSerious infectionsSegmental glomerulosclerosisAntitrypsin deficiencyNegative bacilliKluyvera infectionsMixed organismsAbscess aspirateCommensal organisms